Filter News
Area of Research
News Topics
- (-) Nanotechnology (1)
- (-) Summit (2)
- 3-D Printing/Advanced Manufacturing (2)
- Artificial Intelligence (1)
- Big Data (1)
- Bioenergy (10)
- Biology (18)
- Biomedical (4)
- Biotechnology (4)
- Chemical Sciences (1)
- Clean Water (5)
- Climate Change (5)
- Composites (1)
- Computer Science (3)
- Decarbonization (1)
- Energy Storage (1)
- Environment (24)
- Exascale Computing (1)
- Fusion (1)
- High-Performance Computing (5)
- Materials (3)
- Materials Science (1)
- Mercury (3)
- Microscopy (1)
- Neutron Science (1)
- Polymers (1)
- Security (1)
- Sustainable Energy (8)
Media Contacts
![Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers. Credit: ORNL, U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-11/2008-P01679_0.jpg?h=6acbff97&itok=ewBiiftq)
Ten scientists from the Department of Energy’s Oak Ridge National Laboratory are among the world’s most highly cited researchers, according to a bibliometric analysis conducted by the scientific publication analytics firm Clarivate.
![As part of the Next-Generation Ecosystem Experiments Arctic project, scientists are gathering and incorporating new data about the Alaskan tundra into global models that predict the future of our planet. Credit: ORNL/U.S. Dept. of Energy](/sites/default/files/styles/list_page_thumbnail/public/2021-08/NGEE_eddy%20covariance%20Busey.jpg?h=2d5be524&itok=VFtVDdzq)
Improved data, models and analyses from ORNL scientists and many other researchers in the latest global climate assessment report provide new levels of certainty about what the future holds for the planet
![ATOM logo](/sites/default/files/styles/list_page_thumbnail/public/2021-03/ATOM_Logo_small.png?h=8f9cfe54&itok=Qpezfk8V)
The Accelerating Therapeutics for Opportunities in Medicine , or ATOM, consortium today announced the U.S. Department of Energy’s Oak Ridge, Argonne and Brookhaven national laboratories are joining the consortium to further develop ATOM’s artificial intelligence, or AI-driven, drug discovery platform.